The next generation of complex lung genetic studies

Area of Science:

• Genetics
• Genomics
• Pulmonology

Background:

• Genome-wide association studies (GWAS) have identified common genetic risk variants but explain limited heritability in complex diseases.
• Complex diseases involve heterogeneous genes and multiple rare risk alleles across populations.

Purpose of the Study:

• To highlight the role of next-generation sequencing (NGS) in identifying rare disease variants for complex lung diseases.
• To outline the key steps in designing sequencing projects for rare variant discovery in lung disease.

Main Methods:

• Utilizing next-generation sequencing (NGS) technologies including whole genome, whole exome, and targeted region sequencing.
• Implementing a four-step process: library preparation, sequencing, sequence data analysis, and statistical analysis.
• Leveraging evolving data analysis approaches to identify rare variants associated with complex diseases.

Main Results:

• NGS technologies are now mature and cost-effective for comprehensive rare allele identification.
• Published studies have demonstrated success in identifying rare variants linked to complex diseases.
• Rare variants are crucial for understanding the genetic basis of complex lung diseases.

Conclusions:

• Rare variants are a critical component in unraveling the genetic architecture of complex lung diseases.
• NGS offers a powerful approach to discover these rare variants, overcoming limitations of genotyping.
• Identifying rare variants will advance the development of novel therapeutic strategies for lung diseases.